Special Drug Use-Results Survey of Lipitor Tablets

• Status: Completed
• Trial end date: 2012-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is to evaluate the controlling effect of atrovastatin on plasma lipid to achieve the category-specific targeted lipid levels.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Patients with hypercholesterolemia who have not achieved the category-specific target lipid level